BioSpace News Archive

Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a late-stage biopharmaceutical company focused on developing and commercializing treatments for unmet needs in immune-mediated dermatological diseases and conditions, or immuno-dermatology, today announced preliminary results for the first cohort of 223 subjects from its ongoing Phase 2 long-term safety study evaluating ARQ-151 (topical roflumilast cream) 0.3%

According to the report, the global hospital furniture market was valued at US$ 9.5 Bn in 2019 and is projected to expand at a high CAGR during the forecast period.

Inspired by the pandemic, Brain Navi developed a new robot to perform nasal swab tests autonomously to prevent cross infections so we can save the medical system and reestablish economies.

Company to provide update on its lead drug candidate, GPX-001 for non-small cell lung cancer, and its preclinical diabetes gene therapy candidate that may have the potential to cure Type 1 and Type 2 diabetes

AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company developing first-in-class antibody product candidates focused on emerging immune control mechanisms applicable to inflammation and immuno-oncology indications, today announced the appointment of Paul F. Lizzul, M.D., Ph.D. as Chief Medical Officer. “Paul’s extensive expertise in the development of immune-modulating therapeutics will be instrumental to the advancement of Anapty

Advanced BioCatalytics (ABC) is proud to announce that Glucospike® has been approved by the Environmental Protection Agency’s Safer Choice Program. The federal program recognizes products which have met standards for human and environmental safety. Glucospike® is one of several products in ABC’s new line of Fermactants ™ . Fe

Achieve Life Sciences, Inc. (NASDAQ: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation, today announced that the United States Patent and Trademark Office has granted Achieve a patent (US 2020/0172544 A1) on novel a

The American Red Cross has elected to its National Board of Governors Dave Clark , Senior Vice President, Worldwide Operations for Amazon.com. The Red Cross is led by a Board of Governors with all of th

Helix, the leading population genomics company, today announced that it has been awarded $33.4 M in funding from the National Institutes of Health (NIH) under the Rapid Acceleration of Diagnostics (RADx) program.

Mesa Biotech, developers of an affordable, easy to use, handheld testing platform for infectious diseases diagnosis, today announced it has been awarded a contract up to $15.4 million from the National Institutes of Health’s (NIH) Rapid Acceleration of Diagnostics (RADx) program for its Accula™ SARS-CoV-2 Test, which gives COVID-19 diagnostic results in 30 minutes at the point of care (POC)